Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Walker

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Plos One|October 8, 2013
Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trialSujal M Parikh, Ekwaro A Obuku, Sarah A Walker, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
Eclinicalmedicine|June 14, 2021
Population-level faecal metagenomic profiling as a tool to predict antimicrobial resistance in <i>Enterobacterales</i> isolates causing invasive infections: An exploratory study across Cambodia, Kenya, and the UKOlga Tosas Auguet, Rene Niehus, Hyun Soon Gweon, et al.
The Lancet. Global Health|January 20, 2023
A global core outcome measurement set for snakebite clinical trialsMichael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.
Medecine Tropicale Et Sante Internationale|December 14, 2023
[A global core outcome measurement set for snakebite clinical trials]Michael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.
International Journal of Epidemiology|November 19, 2002
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risksAbdel Babiker, Janet Darbyshire, Patrizio Pezzotti, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Plos One|October 8, 2013
Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trialSujal M Parikh, Ekwaro A Obuku, Sarah A Walker, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
Eclinicalmedicine|June 14, 2021
Population-level faecal metagenomic profiling as a tool to predict antimicrobial resistance in <i>Enterobacterales</i> isolates causing invasive infections: An exploratory study across Cambodia, Kenya, and the UKOlga Tosas Auguet, Rene Niehus, Hyun Soon Gweon, et al.
The Lancet. Global Health|January 20, 2023
A global core outcome measurement set for snakebite clinical trialsMichael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.
Medecine Tropicale Et Sante Internationale|December 14, 2023
[A global core outcome measurement set for snakebite clinical trials]Michael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.
International Journal of Epidemiology|November 19, 2002
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risksAbdel Babiker, Janet Darbyshire, Patrizio Pezzotti, et al.
Pageof 3